Clinical Trial Update: Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort

View source ↗

Summary

A clinical trial evaluating volatile biomarkers in exhaled breath and blood for Crohn's disease has been terminated (validation cohort).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Crohn's Disease | Status: TERMINATED